Ayaka Katayama
Shizuoka Cancer Center(JP)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, AI in cancer detection, HER2/EGFR in Cancer Research
Most-Cited Works
- → Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer(2023)87 cited
- → Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer(2021)82 cited
- → High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients(2017)65 cited
- → Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients(2017)55 cited
- → Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations(2022)52 cited
- → Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer(2022)38 cited
- → FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer(2020)35 cited
- → β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer(2019)33 cited
- → Expression patterns of claudins in patients with triple‐negative breast cancer are associated with nodal metastasis and worse outcome(2017)31 cited
- → High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma(2018)26 cited